We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Edan Instruments

EDAN Instruments manufactures and distributes diagnostic medical equipments in the areas of obstetrics & gynecology, ... read more Featured Products: More products

Download Mobile App





EDAN Presents Medical Imaging, Patient Monitoring, and Diagnostic Solutions

By LabMedica International staff writers
Posted on 19 Nov 2026

Edan Instruments (Shenzhen, China) is showcasing a broad range of medical technologies at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. More...

The company is highlighting solutions across ultrasound imaging, patient monitoring, cardiology, in vitro diagnostics (IVD), obstetrics and gynecology, and veterinary medicine. Featured products include the new Acclarix LX9S ultrasound system, iV100 patient monitor, Smart ECG Web platform, and upgraded i500 blood gas and chemistry analyzer, reflecting EDAN’s emphasis on connected healthcare and integrated clinical workflows.

Making its debut at the exhibition is the Acclarix LX9S ultrasound system, powered by EDAN's SynSight zone sonography platform. The system incorporates a new eSRI imaging algorithm designed to improve image clarity across different clinical applications. It also features a 23.8-inch display, optical trackball, and redesigned touchscreen interface to streamline operation and support diagnostic imaging workflows.

In patient monitoring, EDAN is highlighting the iV100, which functions as both a transport monitor and a multiparameter module within the iV Series. The platform supports real-time PresCCO continuous cardiac output monitoring, advanced physiological parameters, and clinical decision-support applications for critical care. In cardiology, the company's Smart ECG Web platform connects electrocardiography devices across departments and healthcare facilities, enabling centralized ECG data management, review, and reporting. EDAN is also preparing to introduce a wearable Patch Holter capable of recording ECG signals continuously for up to 14 days to help detect intermittent cardiac events.

EDAN is also presenting its i500 blood gas and chemistry analyzer, which combines benchtop testing capabilities with a compact design for critical care settings. The latest upgrade adds a co-oximetry panel and automated quality control functionality. Another featured IVD solution is the H90 Series six-part differential hematology analyzer, which incorporates reticulocyte (RET) detection to expand blood cell analysis capabilities.

The company's broader portfolio includes solutions for fetal and maternal monitoring, intrapartum imaging, endoscopy, colposcopy, and pelvic floor rehabilitation. In veterinary diagnostics, EDAN is highlighting the CC30 Vet biochemistry analysis system, which supports liver and kidney function assessment in pets through a range of testing cartridges and parameters. Through its participation at MEDICA 2026, EDAN is seeking to strengthen collaboration with international healthcare partners while presenting technologies for hospital, laboratory, and veterinary applications.

“Germany and Europe are important partners in the global healthcare industry. As China’s medical technology sector expands internationally, closer collaboration with European healthcare professionals and industry partners can create opportunities for shared progress,” said Alex You, Senior Director of Marketing, Customer Service, Global Connectivity & Integration at EDAN. “By understanding local clinical needs and translating them into accessible, reliable solutions, we can contribute to more effective healthcare. MEDICA offers a valuable opportunity to strengthen these connections and exchange perspectives.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.